SE ID | SE Region | Sample ID | Tissue type | Biosample name | SE rank | Element | Common SNP | eQTL | Risk SNP | TFBS | CRISPR Cas9 | Gene |
---|---|---|---|---|---|---|---|---|---|---|---|---|
SE_01_009600023 | chr3:62781926-62837622![]() |
Sample_01_0096 | B-cell lymphoma | DOHH2 | 23 | 7 | 1666 | 98 | 6 | 76 | 70 | CADPS |
SE_02_099900127 | chr3:62789287-62836159![]() |
Sample_02_0999 | Lymphoma | OCI-LY1_966 | 127 | 23 | 1409 | 80 | 6 | 70 | 70 | CADPS |
SE_02_121800129 | chr3:62791495-62836685![]() |
Sample_02_1218 | Bone marrow | Daudi | 129 | 36 | 1358 | 76 | 6 | 68 | 70 | CADPS |
SE_02_130300385 | chr3:62793057-62835852![]() |
Sample_02_1303 | Lymphoma | RL_tazemetostat | 385 | 21 | 1292 | 72 | 6 | 65 | 70 | CADPS |
SE_02_021300071 | chr3:62794474-62875762![]() |
Sample_02_0213 | Burkitts lymphoma of the left maxilla | Raji_JQ1 | 71 | 4 | 2314 | 132 | 9 | 174 | 359 | CADPS |
SE_01_006700253 | chr3:62794784-62836269![]() |
Sample_01_0067 | Peritoneal effusion: derived from metastatic site: peritoneal cavity | SUDHL6 | 253 | 3 | 1225 | 66 | 6 | 68 | 70 | CADPS |
SE_02_099800220 | chr3:62794963-62835694![]() |
Sample_02_0998 | Lymphoma | OCI-LY1_DMSO | 220 | 40 | 1204 | 65 | 6 | 65 | 70 | CADPS |
SE_01_005500328 | chr3:62795103-62836555![]() |
Sample_01_0055 | Haematopoietic and lymphoid tissue | OCI-LY7 | 328 | 9 | 1221 | 66 | 5 | 68 | 70 | CADPS |
SE_02_021200232 | chr3:62795279-62832184![]() |
Sample_02_0212 | Burkitts lymphoma of the left maxilla | Raji_DMSO | 232 | 6 | 1084 | 57 | 5 | 56 | 70 | CADPS |
SE_01_005300463 | chr3:62795499-62836070![]() |
Sample_01_0053 | Haematopoietic and lymphoid tissue | OCI-LY1 | 463 | 9 | 1199 | 63 | 5 | 68 | 70 | CADPS |
SE_02_122500238 | chr3:62795524-62837458![]() |
Sample_02_1225 | Bone marrow | RAJI | 238 | 29 | 1239 | 67 | 5 | 70 | 70 | CADPS |
SE_02_028800664 | chr3:62815026-62836542![]() |
Sample_02_0288 | Tonsil | CB5_H3K27Ac | 664 | 3 | 622 | 28 | 3 | 37 | 0 | CADPS |
SE_02_077600524 | chr3:62835080-62888370![]() |
Sample_02_0776 | Pancreas | EndoC-BH1 | 524 | 9 | 1441 | 93 | 8 | 181 | 289 | CADPS |
SE_02_003300828 | chr3:62857861-62888793![]() |
Sample_02_0033 | Pancreas | pancreatic-islets-F | 828 | 4 | 893 | 47 | 7 | 175 | 289 | CADPS |
SE_02_049500433 | chr3:62871157-62876232![]() |
Sample_02_0495 | Islets | differentiated hESCs Early LSD1 inhibition PP2 | 433 | 1 | 144 | 9 | 0 | 61 | 289 | CADPS |
SE_02_049400463 | chr3:62871688-62876914![]() |
Sample_02_0494 | Islets | differentiated hESCs Late pancreatic progenitor cells | 463 | 1 | 143 | 10 | 0 | 62 | 289 | CADPS |
SE_02_077501718 | chr3:62871774-62881401![]() |
Sample_02_0775 | Pancreas | EndoC-BH1_SE | 1718 | 3 | 250 | 20 | 2 | 67 | 289 | CADPS |
SE_02_049300920 | chr3:62872165-62876284![]() |
Sample_02_0493 | Islets | differentiated hESCs Early pancreatic progenitor cells | 920 | 2 | 111 | 9 | 0 | 60 | 289 | CADPS |
SE_02_156700798 | chr3:62873118-62886278![]() |
Sample_02_1567 | iPSCs | CiPSC | 798 | 2 | 351 | 27 | 4 | 124 | 289 | CADPS |
SE_02_157200948 | chr3:62873130-62886245![]() |
Sample_02_1572 | iPSCs | FiPSC | 948 | 3 | 351 | 27 | 4 | 124 | 289 | CADPS |
SE_02_067700444 | chr3:62873131-62886076![]() |
Sample_02_0677 | Embryo | H1 hESC-derived neural progenitor cells_Smad_6hr | 444 | 6 | 348 | 27 | 4 | 124 | 289 | CADPS |
SE_02_157000859 | chr3:62873191-62886109![]() |
Sample_02_1570 | iPSCs | EiPSC | 859 | 2 | 346 | 27 | 4 | 124 | 289 | CADPS |
SE_02_077600481 | chr3:62918402-62966148![]() |
Sample_02_0776 | Pancreas | EndoC-BH1 | 481 | 9 | 1536 | 12 | 1 | 66 | 126 | CADPS |
SE_02_018500056 | chr3:62920090-62971722![]() |
Sample_02_0185 | Skin | UACC257 | 56 | 5 | 1698 | 12 | 1 | 63 | 126 | CADPS |
SE_02_018100761 | chr3:62921187-62950891![]() |
Sample_02_0181 | melanoma | COLO679 | 761 | 6 | 908 | 1 | 1 | 54 | 59 | CADPS |